Show Menu

A fully integrated developer and manufacturer of polyclonal therapeutics, targeting infectious disease and acute toxic events

News: Archive for March 2010

Sale of MicroPharm’s Diagnostic Division to Inverness Medical Innovations

MicroPharm announced the sale of the assets of the Diagnostics Division to Inverness Medical Innovations.

Read the full story

Posted on: Thursday, 18th March 2010